Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?

Researchers use AI to reprogram glioblastoma cancer cells

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

With so many CDMOs to choose from, what should you consider before picking your partner? Here’s some advice from Vetter.

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.

How handheld Raman spectroscopy instruments are making a mark in raw materials identification.

The team of dreamers and achievers behind the 2023 Innovation Awards winner, Lonza’s Enprotect Capsule, discuss their technology.

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.